SCHEMBL3390111

SCHEMBL3390111

Cc1ccc(S(=O)(=O)N2C[C@@H]3C[C@@H]3C[C@H]2/C=N/c2ccc(C(F)(F)F)cn2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
POLB P06746 1/20 0.38
PKM P14618 1/20 0.38
KDM4E B2RXH2 2/20 0.37
LMNA P02545 3/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAPK1 P28482 2/20 0.37
PSEN1 P49768 2/20 0.37
PSEN2 P49810 2/20 0.37
APH1B Q8WW43 2/20 0.37
NCSTN Q92542 2/20 0.37
APH1A Q96BI3 2/20 0.37
PSENEN Q9NZ42 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CCR6 P51684 2/20 0.37
GAA P10253 2/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3390120 1.00 ALDH1A1 (0.42) ALDH1A1POLBPKMKDM4ELMNA
SCHEMBL3390175 0.75 CCR6 (0.44) ALDH1A1PKMLMNACCR6GAA
SCHEMBL3390197 0.73 POLB (0.51) ALDH1A1POLBPKMLMNAKMT2A
SCHEMBL6081062 0.65 ALDH1A1 (0.57) ALDH1A1KDM4ELMNAMEN1KMT2A
SCHEMBL29657316 0.63 PKM (0.61) ALDH1A1POLBPKMKDM4ELMNA
SCHEMBL31629999 0.63 PKM (0.61) ALDH1A1POLBPKMKDM4ELMNA
SCHEMBL3386500 0.63 POLB (0.50) ALDH1A1POLBPKMLMNAKMT2A
SCHEMBL3390663 0.63 POLB (0.53) ALDH1A1POLBPKMLMNAKMT2A
SCHEMBL23630333 0.62 MCOLN3 (0.50) ALDH1A1POLBPKMLMNAKMT2A
SCHEMBL3584365 0.62 KMT2A (0.52) ALDH1A1LMNAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100144760-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2010-06-10 US disclosed
US-20100144760-A1 NOVEL COMPOUNDS GLAXO GROUP LIMITED (GB) 2010-06-10 US disclosed
WO-2010063663-A1 N-{[(IR,4S,6R-3-(2-PYRIDINYLCARBONYL)-3-AZABICYCLO [4.1.0]HEPT-4-YL] METHYL}-2-HETEROARYLAMINE DERIVATIVES AND USES THEREOF GLAXO GROUP LIMITED (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100144760-A1 NOVEL COMPOUNDS HTR3B, HTR1B, HTR2B ALDH1A1 882/4885POLB 2243/4885PKM 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.